salmeterol xinafoate has been researched along with Hay Fever in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gutiérrez, V; Marín, J; Prieto, L; Torres, V; Uixera, S | 1 |
Fanat, A; O'Byrne, PM; Parameswaran, K | 1 |
Barbagallo Sangiorgi, G; Di Lorenzo, G; Mansueto, P; Melluso, M; Morici, G; Norrito, F; Purello D'Ambrosio, F | 1 |
Grönneberg, R; Halldén, G; Hed, J; Raud, J; van Hage-Hamsten, M | 1 |
Kagey-Sobotka, A; Lichtenstein, LM; Proud, D; Reynolds, CJ; Togias, A | 1 |
5 trial(s) available for salmeterol xinafoate and Hay Fever
Article | Year |
---|---|
Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Albuterol; Asthma; Breath Tests; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nitric Oxide; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Seasons | 2002 |
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Cross-Over Studies; Drug Synergism; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Membrane Potentials; Nasal Lavage Fluid; Nasal Mucosa; Nasal Obstruction; Nasal Provocation Tests; Nebulizers and Vaporizers; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate | 2006 |
Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics.
Topics: Adult; Albuterol; Asthma; Blood Proteins; Cell Count; Cross-Over Studies; Eosinophil Granule Proteins; Eosinophils; Female; Forced Expiratory Volume; Humans; Hypersensitivity, Immediate; Leukocyte Count; Male; Middle Aged; Peak Expiratory Flow Rate; Pollen; Rhinitis, Allergic, Seasonal; Ribonucleases; Salmeterol Xinafoate | 1995 |
Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients.
Topics: Administration, Cutaneous; Adrenergic beta-Agonists; Adult; Albuterol; Blister; Dermatitis, Atopic; Humans; Middle Aged; Premedication; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Terbutaline | 1996 |
Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration.
Topics: Administration, Intranasal; Adrenergic beta-Agonists; Albuterol; Asthma; Capillary Permeability; Cell Count; Cytokines; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Histamine Release; Humans; Male; Mast Cells; Muramidase; Nasal Lavage Fluid; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Treatment Outcome | 1998 |